hansoh glp 1 Merck pays $112M upfront for Hansoh's preclinical GLP-1 Merck Enters into Exclusive Global
Description
Ratio of serum levels of AGEs to soluble form of RAGE is a predictor of endothelial function
Who Should and Should Not Consider GLP-1 Therapy With Crohn's Disease Candidates for GLP-1 therapy with Crohn's disease typically have well-controlled or remission-stage disease, stable inflammatory markers, adequate nutritional status, and documented need for weight management
Dehydration worsens constipation
Notably, IGF-1 promotes neurogenesis in the hippocampus, and reduced IGF-1 levels have been linked to depressive-like behaviors in animal models [97, 98]
140 However, the administration of SNAC alone did not alter the plasma concentrations of furosemide (an OAT1 and OAT3 substrate) or rosuvastatin (a BCRP and OATP1B1 substrate)
The platform is also one of the few in this space to offer a needle-free oral semaglutide option alongside traditional injectables
